Association between cumulative uric acid to high-density lipoprotein cholesterol ratio and the incidence and progression of chronic kidney disease

被引:3
|
作者
Liu, Peipei [1 ]
Li, Junjuan [2 ]
Yang, Ling [1 ]
Zhang, Zihao [1 ]
Zhao, Hua [3 ]
Zhao, Naihui [1 ]
Ou, Wenli [1 ]
Zhang, Yinggen [4 ]
Chen, Shuohua [5 ]
Wang, Guodong [5 ]
Zhang, Xiaofu [3 ]
Wu, Shouling [5 ]
Yang, Xiuhong [1 ,3 ]
机构
[1] North China Univ Sci & Technol, Sch Publ Hlth, Tangshan, Hebei, Peoples R China
[2] Kailuan Gen Hosp, Dept Neurol, Tangshan, Hebei, Peoples R China
[3] North China Univ Sci & Technol, Sch Basic Med Sci, Hebei Key Lab Chron Dis, Tangshan Key Lab Preclin & Basic Res Chron Dis, Tangshan, Hebei, Peoples R China
[4] Kailuan Gen Hosp, Dept Nucl Med, Tangshan, Hebei, Peoples R China
[5] Kailuan Gen Hosp, Dept Cardiol, Tangshan, Hebei, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
chronic kidney disease; progression; uric acid to high-density lipoprotein cholesterol ratio; cumulative exposure; UHR; RISK; CKD; INDIVIDUALS; MANAGEMENT; PREDICTOR;
D O I
10.3389/fendo.2023.1269580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The ratio of uric acid to high-density lipoprotein cholesterol (UHR) was related to the risk of chronic kidney disease (CKD), we aimed to investigate the association of cumulative UHR (cumUHR) with incidence and progression of CKD.Methods: Our study included a total of 49,913 participants (mean age 52.57 years, 77% males) from the Kailuan Study conducted between 2006 and 2018. Participants who completed three consecutive physical examinations were included. Cumulative UHR (cumUHR) was computed as the summed average UHR between two consecutive physical examinations, multiplied by the time between the two examinations. Participants were then categorized into four groups based on cumUHR quartiles. Subsequently, participants were further divided into a CKD group and a non-CKD group. The associations between cumUHR and CKD and it's progression were assessed by Cox proportional hazards regression models. The cumulative incidence of endpoint events was compared between the cumUHR groups using the log-rank test. The C-index, net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were calculated to assess the predictive performance of cumUHR.Results: After a mean follow-up of 8.0 +/- 1.7 years, there were 4843 cases of new-onset CKD, 2504 of low eGFR, and 2617 of proteinuria in the non-CKD group. Within the CKD group, there were 1952 cases of decline in eGFR category, 1465 of >30% decline in eGFR, and 2100 of increased proteinuria. In the non-CKD group, the adjusted hazard ratios (HRs) and confidence intervals (CIs) in the fourth quartile were 1.484 (1.362-1.617), 1.643 (1.457-1.852), and 1.324 (1.179-1.486) for new-onset CKD, low eGFR, and proteinuria, respectively. In the CKD group, the adjusted HRs in the fourth quartile were 1.337 (1.164-1.534), 1.428 (1.216-1.677), and 1.446 (1.267-1.651) for decline in eGFR category, >30% decline in eGFR, and increase in proteinuria, respectively. In addition, we separately added a single UHR measurement and cumUHR to the CKD base prediction model and the CKD progression base prediction model, and found that the models added cumUHR had the highest predictive value.Conclusion: High cumUHR exposure was an independent risk factor for the incidence and progression of CKD, and it was a better predictor than a single UHR measurement.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Association between serum uric acid to high density lipoprotein-cholesterol ratio and arterial stiffness in a Japanese population
    Wang, Haidong
    Ba, Yudong
    Gao, Xuede
    Zhuo, Jinxiu
    Li, Yanan
    Sun, Jianhua
    Zhang, Shuxian
    [J]. MEDICINE, 2023, 102 (31) : E34182
  • [32] Association between the Ratio of Triglycerides to High-Density Lipoprotein Cholesterol and Chronic Kidney Disease in Korean Adults: The 2005 Korean National Health and Nutrition Examination Survey
    Kang, Hee-Taik
    Shim, Jae-Yong
    Lee, Yong-Jae
    Lee, Jung-Eun
    Linton, John A.
    Kim, Jong-Koo
    Lee, Hye-Ree
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2011, 34 (03): : 173 - 179
  • [33] Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and kidney stone: evidence from NHANES 2007-2018
    Chen, Tao
    Cheng, Yu
    Song, Zheng
    Zhang, Gan
    Zeng, Tao
    Chao, Haichao
    [J]. BMC PUBLIC HEALTH, 2024, 24 (01)
  • [34] Total cholesterol to high-density lipoprotein cholesterol ratio is independently associated with CKD progression
    Li, Wei
    Du, Zhijie
    Wei, Honglan
    Dong, Junwu
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (08) : 2057 - 2063
  • [35] Total cholesterol to high-density lipoprotein cholesterol ratio is independently associated with CKD progression
    Wei Li
    Zhijie Du
    Honglan Wei
    Junwu Dong
    [J]. International Urology and Nephrology, 2022, 54 : 2057 - 2063
  • [36] High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
    Baragetti, A.
    Norata, G. D.
    Sarcina, C.
    Rastelli, F.
    Grigore, L.
    Garlaschelli, K.
    Uboldi, P.
    Baragetti, I.
    Pozzi, C.
    Catapano, A. L.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2013, 274 (03) : 252 - 262
  • [37] Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and diabetic kidney disease in patients with diabetes in the United States: a cross-sectional study
    Pan, Jingjing
    Li, Changnian
    Zhang, Jiayi
    Sun, Zhenhua
    Yu, Xiaoying
    Wan, Qianhui
    Ruan, Zhishen
    Wang, Wenbo
    Li, Yujie
    [J]. LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [38] The Association Between the Triglyceride to High-Density Lipoprotein Cholesterol Ratio and the Incidence of Type 2 Diabetes Mellitus in the Japanese Population
    Xu, Guojuan
    Song, Jing
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2024, 22 (06) : 471 - 478
  • [39] Indoxyl sulfate and high-density lipoprotein cholesterol in early stages of chronic kidney disease
    Wang, Li
    Xiang, Fangfang
    Ji, Jun
    Ding, Xiaoqiang
    Shen, Bo
    Chen, Jing
    Chen, Yunqin
    Xue, Ning
    Zhang, Lin
    Jiang, Xiaotian
    Cao, Xuesen
    [J]. RENAL FAILURE, 2020, 42 (01) : 1157 - 1163
  • [40] High-Density Lipoprotein Lipidomics in Chronic Kidney Disease
    Lidgard, Benjamin
    Hoofnagle, Andrew N.
    Zelnick, Leila R.
    de Boer, Ian H.
    Fretts, Amanda M.
    Kestenbaum, Bryan R.
    Lemaitre, Rozenn N.
    Robinson-Cohen, Cassianne
    Bansal, Nisha
    [J]. CLINICAL CHEMISTRY, 2023, 69 (03) : 273 - 282